Clinical Trials on Immune Checkpoint Inhibitor in Belgium

Total 1767 results

MacroGenics

Recruiting

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint Molecule

United States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
Algemeen Ziekenhuis Maria Middelares

Recruiting

Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors (CAVACI)

Cancer | Atherosclerosis | Cardiotoxicity | Diastolic Dysfunction | Immune Checkpoint Inhibitor-Related Myocarditis | Immune-related Adverse Event | Cardiac Abnormalities, Variable

Belgium
University Ghent
Research Foundation Flanders

Recruiting

The Effect of Cognitive Dual-task Rehabilitation on Arthrogenic Muscle Responses After ACL Reconstruction (AMIRA)

Anterior Cruciate Ligament Reconstruction | ACL Injury | Athrogenic Muscle Responses | Arthrogenic Muscle Inhibition

Belgium
R&D Cardiologie

Completed

WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing) (WOEST)

Atrial Fibrillation | Stents | Anticoagulants | Platelet Aggregation Inhibitors

Netherlands, Belgium
Insel Gruppe AG, University Hospital Bern
Sahajanand Medical Technologies Limited

Recruiting

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation (MATRIX-2)

Atrial Fibrillation (AF) | Oral Anticoagulation | Percutaneous Coronary Intervention (PCI) | P2Y12 Inhibitor

Spain, France, Switzerland, United Kingdom, Germany, Belgium, Italy, Netherlands, Poland
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors (HAVEN 6)

Hemophilia A | Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor | Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor

United States, Netherlands, Belgium, France, Germany, South Africa, Spain, Canada, United Kingdom, Poland
University Hospital Inselspital, Berne
European Cardiovascular Research Center

Completed

GLOBAL LEADERS Adjudication Sub-Study (GLASSY)

Coronary Artery Disease | Platelet-aggregation Inhibitors

Bulgaria, Switzerland, Austria, Belgium, Germany, Italy, Netherlands, Poland, United Kingdom
Universitair Ziekenhuis Brussel

Recruiting

Food Intervention to Reduce Immunotherapy toXicity (FORX01)

Dietary Habits | Immune-related Adverse Event

Belgium
University Hospital, Ghent

Recruiting

The Influence of Hormone Replacement Therapy and Supervised Exercise Training on Body Composition, Cardiovascular Risk and Insulin Sensitivity in Postmenopausal Women (OPERATE)

Postmenopause

Belgium
Agomab Spain S.L.

Completed

Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants

Healthy Volunteers

Belgium
GlaxoSmithKline

Completed

Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose

AIDS

Belgium
ViiV Healthcare
Pfizer

Completed

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Healthy

Belgium
Janssen R&D Ireland

Completed

A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin

Healthy

Belgium
ViiV Healthcare
Pfizer

Completed

Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects

Healthy

Belgium
Novo Nordisk A/S

Completed

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors (ONE)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

Saudi Arabia, Algeria, Turkey, Germany, Poland, Netherlands, Italy, Belgium, South Africa, United Kingdom, Sweden, Austria, Portugal, France, Czech Republic, Venezuela
Janssen Sciences Ireland UC

Completed

Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination

Healthy

Belgium
Pfizer

Completed

The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects

Healthy Volunteers

Belgium
Brugmann University Hospital

Recruiting

Impact of Microbial Exposure of the Habitat at the Time of Birth on the Development of Allergic Diseases.

Allergic Disorder

Belgium
Mymetics Corporation
Institut Cochin; San Raffaele University Hospital, Italy; Kinesis Pharma B.V.; ... and other collaborators

Completed

Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects

HIV-1

Belgium
Institut Pasteur

Completed

Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine

HIV

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Effect of Intragastric Administration of Fatty Acids on Generalized Reward Sensitivity

Healthy Volunteers

Belgium
GlaxoSmithKline

Completed

Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects

AIDS | AIDS Vaccines

Belgium
KU Leuven

Terminated

ERNIE4: Urine and CRP Point-of-care Test in Acutely Ill Children (ERNIE4)

Infection

Belgium
Queen Astrid Military Hospital

Recruiting

Allergy Testing of Soldiers Prepared for International Mission (SPAT_ABL)

Adult Military Personnel

Belgium
Universitair Ziekenhuis Brussel

Terminated

Body Composition, Bone Health and Hormonal Status in HIV-1-infected Individuals (BONBO)

HIV-1 | Treatment-naïve

Belgium
Brugmann University Hospital

Completed

Impact of Age on the Prevalence of Allergic Sensitization

Allergy

Belgium
Chiesi Farmaceutici S.p.A.

Completed

PK Linearity and Steady State PK of CHF 6532 in Healthy Subjects

Asthma

Belgium
Pfizer

Completed

To Test The Relative Bioavailability Of PF-04191834 When Dosed As An Immediate Release Tablet Compared With Solution Following Single And Multiple Dosing

Asthma

Belgium
KU Leuven

Completed

The Influence of Oxytocin on Socio-communicative Sensitivity

Oxytocin

Belgium
University Hospital, Antwerp
Universiteit Antwerpen

Active, not recruiting

B-lactam Databank Algorithm

Beta Lactam Adverse Reaction

Belgium
University of Liege

Completed

Effect of Dolutegravir Intensification on HIV-1 Reservoirs (EDIT)

HIV-1-infection

Belgium
University Hospital, Ghent

Withdrawn

Measuring the HIV-1 Reservoir During Cure Interventions Studies (MERCI)

Hiv

Belgium
Sanofi

Completed

A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or Lymphoma

Neoplasm Malignant

Belgium
Pfizer

Completed

A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04629991 in Healthy Volunteers

Healthy Volunteers

Belgium
Pfizer

Completed

Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy Volunteers

Healthy

Belgium
Chiesi Farmaceutici S.p.A.

Completed

Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy Volunteers

Asthma

Belgium
University Hospital, Ghent
Merck Sharp & Dohme LLC

Completed

HIV Sequencing After Treatment Interruption to Identify the Clinically Relevant Anatomical Reservoir (HIV-STAR)

HIV

Belgium
GlaxoSmithKline

Completed

Study in Allergic Adults to Support the Development of Immunological Assays

Immunologic Tests

Belgium
Cliniques universitaires Saint-Luc- Université...
Université Catholique de Louvain

Completed

Pharmacogenomics of New Antiretrovirals

HIV

Belgium
OSE Immunotherapeutics
Servier

Completed

Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects

Healthy Subjects

Belgium
Jessa Hospital

Completed

Safety of a Powder-free Latex Allergy Protocol in the Operating Theatre: A Prospective, Observational Cohort Study

Latex Hypersensitivity | Latex Allergy

Belgium
General Hospital Groeninge

Completed

A Clinical Trial to Evaluate the Sensitivity of a Number of Clinical and Psychological Outcome Measures for Cancer Patients Being Treated at the Hospital Day Care Unit or (Partially) at Home

Cancer

Belgium
Francis Corazza

Recruiting

Evaluation of the Clinical Performances of a Point of Care Analyzer Enabling Pre-transfusion ABOD Group Ultimate Verification at the Patient Bedside

Blood Transfusion Complication

Belgium
Brugmann University Hospital

Completed

Prevalence of Antiphospholipid Antibodies in the Hemodialysis Patients Population Within the CHU Brugmann Hospital

Antiphospholipid Syndrome

Belgium
Université Catholique de Louvain

Terminated

Perioperative Evaluation of Immuno-inflammatory Parameters

Combined Inflammatory and Immunologic Defect

Belgium
United Pharmaceuticals

Completed

Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy (Paradice)

Milk Hypersensitivity | Food Sensitivity | Protein Allergy

Belgium
Janssen R&D Ireland

Completed

A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions

Healthy Participants

Belgium
Patrick Durez

Completed

A 6-Months Infliximab Or Placebo Study In UA At High Risk Of RA:Clinical,Radiological And Synovial Benefit (UA-IFX)

Undifferentiated Arthritis

Belgium
Sanofi

Completed

Extension to Study HMR1964A/3011 in Belgium

Diabetes Mellitus

Belgium
Pfizer

Completed

Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants

Healthy

Belgium

3

Subscribe